{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:18:34Z","timestamp":1760955514552},"reference-count":28,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.07.065","type":"journal-article","created":{"date-parts":[[2014,7,30]],"date-time":"2014-07-30T06:30:20Z","timestamp":1406701820000},"page":"5163-5169","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A national reference for inactivated polio vaccine derived from Sabin strains in Japan"],"prefix":"10.1016","volume":"32","author":[{"given":"Haruko","family":"Shirato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Someya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohide","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naokazu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumitsu","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Tano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shudo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaji","family":"Wakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.07.065_bib0005","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.122.3159.105","article-title":"Emerging concept of poliomyelitis infection","volume":"122","author":"Bodian","year":"1955","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0010","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.123.3209.1151","article-title":"Pathogenesis of poliomyelitis: reappraisal in the light of new data","volume":"123","author":"Sabin","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0015","unstructured":"WHO. The global polio eradication on initiative. http:\/\/www.polioeradication.org\/Dataandmonitoring.aspx."},{"key":"10.1016\/j.vaccine.2014.07.065_bib0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.7883\/yoken.JJID.2008.100","article-title":"Poisson-model analysis of the risk of vaccine-associated paralytic poliomyelitis in Japan between 1971 and 2000","volume":"61","author":"Hao","year":"2008","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0025","series-title":"Vaccines","first-page":"631","article-title":"Poliovirus vaccine-live","author":"Sutter","year":"2008"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0030","unstructured":"WHO. Polio eradication & endgame strategic plan 2013\u20132018. http:\/\/www.polioeradication.org\/resourcelibrary\/strategyandwork.aspx."},{"key":"10.1016\/j.vaccine.2014.07.065_bib0035","unstructured":"WHO global action plan to minimize poliovirus facility-associated risk after eradication of wild polioviruses and cessation of routine OPV use. http:\/\/www.polioeradication.org\/Portals\/0\/Document\/Resources\/PostEradication\/GAP3_2009.pdf."},{"key":"10.1016\/j.vaccine.2014.07.065_bib0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biologicals.2006.02.011","article-title":"Technology transfer of Sabin-IPV to new developing country markets","volume":"34","author":"Kreeftenberg","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0045","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0050","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00006454-198811000-00003","article-title":"Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey","volume":"7","author":"Murph","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0055","first-page":"163","article-title":"Progress with inactivated poliovirus vaccines derived from the Sabin strains","volume":"105","author":"Doi","year":"2001","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0060","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.vaccine.2011.02.085","article-title":"Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines","volume":"29","author":"Westdijk","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1586\/erv.11.51","article-title":"Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains","volume":"10","author":"Verdijk","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0070","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1016\/j.vaccine.2013.09.021","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults","volume":"31","author":"Verdijk","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.biologicals.2006.02.010","article-title":"Development of inactivated poliovirus vaccine derived from Sabin strains","volume":"34","author":"Simizu","year":"2006","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/biol.1996.0060","article-title":"A new WHO International Reference Reagent for use in potency assays of inactivated poliomyelitis vaccine","volume":"25","author":"Wood","year":"1997","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0085","unstructured":"WHO Technical Working Group Meeting on Revision of the WHO Recommendations for the Production and Control of Inactivated Poliomyelitis Vaccines: TRS No. 910, Annex 1. http:\/\/www.who.int\/biologicals\/areas\/vaccines\/IPV_Meeting_TRS_Revision_14-15_May_2013_Report_FINAL_22112013.pdf."},{"key":"10.1016\/j.vaccine.2014.07.065_bib0090","first-page":"159","article-title":"New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines","volume":"41","author":"van Wezel","year":"1978","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0095","doi-asserted-by":"crossref","first-page":"7041","DOI":"10.1016\/j.vaccine.2007.07.060","article-title":"Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains","volume":"25","author":"Tano","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0100","series-title":"Statistical methods in biological assay","author":"Finney","year":"1978"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/1045-1056(95)90017-9","article-title":"A WHO collaborative study on assays of the antigenic content of inactivated poliovirus vaccines","volume":"23","author":"Wood","year":"1995","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/biol.1995.0049","article-title":"A WHO collaborative study on assays of immunogenicity assays of inactivated poliovirus vaccines","volume":"23","author":"Wood","year":"1995","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0115","series-title":"WHO Expert Committee on Biological Standardization fifty-first report. Geneva. Annex 2","first-page":"32","article-title":"Requirements for poliomyelitis vaccine (inactivated)","volume":"vol. 910","author":"World Health Organization","year":"2002"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0120","first-page":"119","article-title":"Potency testing of killed polio vaccine in rats","volume":"47","author":"van Steenis","year":"1981","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/00401706.1959.10489859","article-title":"Simplified estimators for the normal distribution when samples are singly censored or truncated","volume":"1","author":"Cohen","year":"1959","journal-title":"Technometrics"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0130","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/clinchem\/25.12.2011","article-title":"A statistical method for determining normal ranges from laboratory data including values below the minimum detectable value","volume":"25","author":"Tsay","year":"1979","journal-title":"Clin Chem"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jit155","article-title":"Phase II and III clinical studies of diphtheria\u2013tetanus\u2013acellular pertussis vaccine containing inactivated polio vaccine derived from Sabin strains (DTaP-sIPV)","volume":"208:","author":"Okada","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.07.065_bib0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir723","article-title":"Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial","volume":"205","author":"Liao","year":"2012","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14010172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14010172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T16:27:35Z","timestamp":1689438455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14010172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":28,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14010172"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.065","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A national reference for inactivated polio vaccine derived from Sabin strains in Japan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}